ANTI-MAG NEUROPATHY
Clinical trials for ANTI-MAG NEUROPATHY explained in plain language.
Never miss a new study
Get alerted when new ANTI-MAG NEUROPATHY trials appear
Sign up with your email to follow new studies for ANTI-MAG NEUROPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare nerve disorder: rituximab trial targets daily function
Disease control Recruiting nowThis study tests if the drug rituximab can improve daily activities in people with Anti-MAG neuropathy, a rare nerve condition that causes progressive disability. About 90 adults with early-stage disease (5 years or less) and specific antibody levels will receive rituximab. The m…
Matched conditions: ANTI-MAG NEUROPATHY
Phase: PHASE3 • Sponsor: Centre Hospitalier Universitaire de Saint Etienne • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
Scientists probe nerve signals to unravel rare nerve diseases
Knowledge-focused Recruiting nowThis study aims to learn more about how nerves work in people with Charcot-Marie-Tooth disease and other nerve disorders like CIDP. Researchers will use special electrical tests and ultrasound to measure nerve responses and structure. The study involves 39 adults and does not tes…
Matched conditions: ANTI-MAG NEUROPATHY
Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta • Aim: Knowledge-focused
Last updated May 18, 2026 12:04 UTC